Efficacy and safety of octreotide in preventing complications after pancreas transplantation: A meta-analysis of randomized trials

Chinese Journal of Evidence-Based Medicine

Volumn 8, Issue 4, 2008, Pages 267-272

  Li, Lu Lu ^a   Li, Yong Sheng ^a   Pang, Li Li ^a   Zhao, Na ^a   Feng, Li ^a   Li, Sheng Fu ^a   Long, Dan ^a   Li, You Ping ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Complication; Octreotide; Pancreas transplantation; Prophylaxis; Systematic review

Indexed keywords

AMYLASE; CYCLOSPORIN A; OCTREOTIDE; TACROLIMUS;

CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; COMPUTER PROGRAM; CONFIDENCE INTERVAL; CONTROL GROUP; DATA ANALYSIS; DRUG EFFICACY; DRUG SAFETY; EMBASE; ENZYME BLOOD LEVEL; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; INFORMATION PROCESSING; MEDLINE; META ANALYSIS; PANCREAS FISTULA; PANCREAS TRANSPLANTATION; PANCREATITIS; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURVIVAL RATE; SYSTEMATIC REVIEW; THROMBOSIS;

EID: 43049122160     PISSN: 16722531     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Gruessner AC, Sutherland DER. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant, 2005, 19: 433-455.
2. Humar A, Ramcharan T, Kandaswamy R, et al. The impact of donor obesity on outcomes after cadaver pancreas transplants: Why grafts fail and the risk factors-A multivariate analysis. Transplantation, 2004, 78(8): 1188-1192.
3. Cooper M, Wringht F, Smith J, et al. Successful treatment of a high-output fistula with a somatostatin analogue following pancreas transplantation. Transplantation Proceedings, 1989, 21(4): 3738-3741.
4. Stratta R, Taylor R, Lowell J, et al. Selective use of sandostatin in vascularized pancreas transplantation. American Journal of Surgery, 1993, 166(6): 598-604.
5. Hesse UJ, Meester D, Troisi R, et al. The use of low dose octreotide prophyaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial. Clin Transplant, 2005, 19(3): 299-303
6. Benedetti E, Coady NT, Asolati M, et al. A prospective randomized clinical trial of perioperative treatment with octreotide in pancreas transplantation. Am J Surg, 1998, 175(1): 14-17.
7. Stratta RJ, Taylor RJ, Lowell JA, et al. Randomized trial of Sandostatin prophylaxis for preservation injury after pancreas transplantation. Transplant Proceedings, 1993, 25(6): 3190-3192.
8. Bogetti D, Nazatrwski S, Zielinski A, et al. Perioperative treatment with octreotide minimizes technical complications after enteric conversion of bladder-drained pancreas trandplants. Clin Transplant, 2004, 18(2): 137-141.
9. Zielinski A, Nazatrwski S, Bogetti D, et al. Simultaneous pancreas-kidney transplant from living related donor: A single-center experience. Transplantation, 2003, 76(3): 547-552.
10. Wadstrom J, Gannedahl G, Wahlberg J, et al. Persistent pancreatic fistula after pancreas transplantation treated with fibrin glue and octreotide. Transplant Proceedings, 1995, 27(6): 3491-3492.
11. Chinese source